Exposing Pharma Strategies to Dominate the US Cannabis Market - by Theresa Yarbrough, Georgia Cannabis Industry Alliance Introduction Federal rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA) stands poised to be the most significant regulatory cataly...
Share this page with your family and friends.